Evidence map›Paper›PMID 23285084›Full record

ArticlePloS one2012

miR-17-5p regulates endocytic trafficking through targeting TBC1D2/Armus.

Andrius Serva, Bettina Knapp, Yueh-Tso Tsai, Christoph Claas, Tautvydas Lisauskas, Petr Matula, Nathalie Harder, Lars Kaderali, Karl Rohr, Holger Erfle and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. TBC1D2 Promotes Ovarian Cancer MetastasisFrontiers in oncology · 2022
    Article
  9. MicroRNAs in IgA nephropathy.Renal failure · 2021
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Biology of MiR-17-92 Cluster and Its Progress in Lung Cancer.International journal of medical sciences · 2018
    Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 3 countries.

Andrius ServaBioQuant, University of Heidelberg, Heidelberg, Germany.
Bettina Knapp
Yueh-Tso Tsai
Christoph Claas
Tautvydas Lisauskas
Petr Matula
Nathalie Harder
Lars Kaderali
Karl Rohr
Holger Erfle
Roland Eils
Vania Braga
Vytaute Starkuviene
Heidelberg University · DEImperial College London · GBMasaryk University · CZ

Funding

Cancer Research UK 11980Medical Research Council G0600791
6 · The paper itself

Abstract

miRNA cluster miR-17-92 is known as oncomir-1 due to its potent oncogenic function. miR-17-92 is a polycistronic cluster that encodes 6 miRNAs, and can both facilitate and inhibit cell proliferation. Known targets of miRNAs encoded by this cluster are largely regulators of cell cycle progression and apoptosis. Here, we show that miRNAs encoded by this cluster and sharing the seed sequence of miR-17 exert their influence on one of the most essential cellular processes - endocytic trafficking. By mRNA expression analysis we identified that regulation of endocytic trafficking by miR-17 can potentially be achieved by targeting of a number of trafficking regulators. We have thoroughly validated TBC1D2/Armus, a GAP of Rab7 GTPase, as a novel target of miR-17. Our study reveals regulation of endocytic trafficking as a novel function of miR-17, which might act cooperatively with other functions of miR-17 and related miRNAs in health and disease.

Indexed as

Base SequenceCell ProliferationDown-RegulationEndocytosisEpidermal Growth FactorGene Expression ProfilingGene Expression Regulation, NeoplasticGTPase-Activating ProteinsHeLa CellsHumansMicroRNAsMolecular Sequence DataProtein Structure, TertiaryProtein TransportReceptors, LDLReproducibility of ResultsEpidermal Growth FactorGTPase-Activating ProteinsLDLR protein, humanMicroRNAsMIRN17 microRNA, humanReceptors, LDLRNA, MessengerTBC1D2 protein, human

Identifiers

PMID23285084
PMCPMC3527550
OpenAlexW1990941407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.